Here is the synopsis of our sample research paper on Distribution Channel and Pricing for an Orphan Drug in Japan. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 5 page paper considers a Chinese pharmaceutical company that want to sell an orphan drug in Japan. The paper starts by justifying Japan as a market choice and then considers the way that the distribution channel and the pricing will be determined, comparing Japan with the home market. The bibliography cites 5 sources.
Page Count:
5 pages (~225 words per page)
File: TS14_TEdrugjap.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
product. When an orphan drug is developed there is a very specific target market in mind; those that suffer from the rare disease or condition that it is designed to
treat. Therefore, when looking for a market to promote the drug part of the decision will be based on the condition that the drug is designed to treat, the issue
then becomes one of which market in terms of geographical location. In this paper there is a desire to sell the drug to the hone market; China and an
international market; Japan. In order to develop a marketing plan the paper will first look at Japan and the reason why it has been selected and then consider the channel
for the marketing and the pricing strategies. 2. The Markets The development of Orphan drugs are encouraged by government, it is a market that makes it possible for
small pharmaceutical companies to compete as the conditions orphan drugs treat, are by the definition rare and as such there is only a relatively small market for them. The decision
to market the drug in the home nation; China is self explanatory. The decision to market the drug in Japan is based on the attractiveness of the market. The
Japanese pharmaceutical market in 2006 the market accounted for approximately 11% of the global pharmaceutical market and was worth $60 billion (Bioportfolio, 2006). This is therefore a developed market that
had a developed and well established infrastructure for the distribution and sale of prescription drugs. The market for an orphan drug will also be determined by those who are
suffering from the condition it is designed to treat, so it is assumed that there is a sufficient number of sufferer in Japan that are suffering from the condition, and
...